Download | < Back |
25 Apr 2017 | |
Glenmark Pharmaceuticals Initiates Clinical Investigation for GBR 310, its Proposed Biosimilar Candidate for XOLAIR With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |